Peptide Surf a research-only wiki of supplements & peptides
Research & educational use only. This site catalogs published research and public commentary about supplements and peptides. It is not medical advice and not a recommendation to use any compound. Consult a qualified clinician.
← Catalog

Tesamorelin

peptide Growth Hormone AxisMetabolic & Weight Management

A stabilized GHRH analog with one of the strongest evidence bases in the growth-hormone-secretagogue category. FDA-approved (Egrifta) for reduction of visceral adipose tissue in HIV-associated lipodystrophy.

Synonyms

Egrifta · brand TH9507 · other GHRH analog · other

Synonyms drive on-site search and are used to index ingested research papers and tweets to this page.

Safety

Contraindications

  • Pregnancy
  • Disrupted hypothalamic-pituitary axis / active malignancy (per labeling)

Reported side effects

  • Injection-site reactions, arthralgia, fluid retention

FDA-approved for a specific indication. This page summarizes public information and commentary and is not medical advice.

Protocols

No structured protocols recorded.

Claims & evidence

Reduces visceral adipose tissue; FDA-approved for HIV-associated lipodystrophy.

Visceral fat reduction positive meta-analysis

Notes

Overview

Tesamorelin is distinguished within this category by an approved indication and comparatively strong clinical evidence for visceral fat reduction.